Offer - Urjas Oil for just ₹ 1 X
Atorlip F is a prescription medicine that is available as a Tablet. Atorlip F also has some secondary and off-label uses. These are listed below.
The optimal dosage of Atorlip F is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Atorlip F side effects, there are can be others also. These have been listed below. These side effects of Atorlip F are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Atorlip F is Moderate for pregnant women and Moderate for women who are breastfeeding. It is important to know if Atorlip F has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Atorlip F related warnings section.
Atorlip F is contraindicated in people with pre-existing medical conditions like Allergy, Kidney Disease, Liver Disease as it can result in adverse effects.
Drug reaction of Atorlip F with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Atorlip F, it is important to know that it is safe while driving, and is habit-forming.
Atorlip F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Atorlip F safe for pregnant women?
Pregnant women may experience moderate side effects from Atorlip F. It is best to stop taking Atorlip F immediately and inform your doctor if you notice any discomfort.
Is the use of Atorlip F safe during breastfeeding?
Breastfeeding women may feel side effects of Atorlip F. If you see any side effects, stop taking Atorlip F immediately and talk to your doctor. Take Atorlip F again, only after your doctor's advice.
What is the effect of Atorlip F on the Kidneys?
Kidney can be affected by Atorlip F. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Atorlip F on the Liver?
Atorlip F has very mild side effects on the liver.
What is the effect of Atorlip F on the Heart?
In the absence of any scientific study on the side effects of Atorlip F on the heart, information on safety of Atorlip F for the heart is unavailable.
Atorlip F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Atorlip F unless your doctor advises you to do so -
Is this Atorlip F habit forming or addictive?
No, you will not get addicted to Atorlip F.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Atorlip F as it does not make you drowsy.
Is it safe?
Yes, but consume Atorlip F only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Atorlip F in mental disorders is not effective.
Interaction between Food and Atorlip F
Taking Atorlip F with food does not cause any problems.
Interaction between Alcohol and Atorlip F
Consumption of alcohol and Atorlip F together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552